The findings of the fatty-liver and the large-visceral-fat-area groups show significant differences in hypertension disease (50% vs. 20%, p < 0.05), metabolic syndrome (57% vs. 44%, p < 0.05) diabetes (52% vs. 27%, p < 0.05), alanine aminotransferases (39 ± 21 vs. 31 ± 17, p < 0.05), and triglyceride levels (197 ± 103 vs. 182 ± 90, p < 0.05), respectively (Table 1). Here, GPT is linked to metabolic syndrome.